Changes of sTWEAK and IL-6 levels in patients with acute coronary syndrome and its clinical signifi-cance
10.3969/j.issn.1008-0074.2016.06.07
- VernacularTitle:sTWEAK 、 IL-6水平在急性冠脉综合征的变化及其临床意义
- Author:
Xiuyan WANG
;
Xiaohui ZHAO
;
Libo WANG
;
Jun YANG
;
Shuhong LI
- Keywords:
TNF-related apoptosis-inducing ligand;
Interleukin-6;
Coronary heart disease;
Acute coronary syndrome
- From:
Chinese Journal of cardiovascular Rehabilitation Medicine
2016;25(6):584-586
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore diagnostic value of soluble tumor necrosis factor - like weak inducer of apoptosis (sTWEAK) and interleukin (IL) -6 concentrations in patients with acute coronary syndrome (ACS) .Methods:A total of 170 ACS patients hospitalized in our hospital from Jan 1st ,2014 to Jun 31st ,2014 were selected as ACS group ,mean‐while ,80 inpatients with stable angina pectoris (SAP) confirmed by coronary angiography (CAG) or coronary CT were se‐lected as SAP group ,and another 80 patients excluded for coronary heart disease (CHD) by CAG were regarded as normal control group .ACS group was further divided into ST elevation myocardial infarction (STEMI) group (n=45) ,non -STEMI (NSTEMI) group (n=52) and unstable angina pectoris (UAP) group (n=73) .Plasma sTWEAK and serum IL‐6 concentrations were compared among all groups .Results:Compared with normal control group and SAP group ,there were significant rise in concentrations of plasma sTWEAK [ (120.32 ± 10.15) ng/L vs .(123.86 ± 15.23) ng/L vs .(140.05 ± 17.51) ng/L] and serum IL‐6 [ (110.34 ± 26.01) pg/ml vs .(112.38 ± 25.74) pg/ml vs .(245.23 ± 68.58) pg/ml] (P<0.01 all) ,but there were no significant difference between normal control group and SAP group , P>0.05. There were no significant difference in plasma sTWEAK and serum IL‐6 concentrations among UAP group ,NSTEMI group and STEMI group , P>0.05 all .Conclusion:Plasma sTWEAK and serum IL‐6 concentrations significantly rise in ACS patients ,which possesses certain diagnostic value for ACS .
